Transitions Optical and the US National Council of Negro Women (NCNW) are collaborating to raise awareness about the importance of proper vision care and vision wear among the Africa-American community.
Teva partners with Klinge Biopharma for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)
The commercialisation agreement for the biosimilar to aflibercept (Eylea) covers Israel and major parts of Europe, excluding Italy
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Study explores possible applications of retinal imaging in schizophrenia detection
The study built on previous research indicating specific retinal variables can serve as disease-related biomarkers in neurodegenerative diseases
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
ViGeneron receives rare paediatric disease designation from US FDA for retinitis pigmentosa gene therapy candidate VG901
ViGeneron, based in Munich, also received approval for dose escalation in the ongoing phase 1b clinical trial
Conjunctival bacteria linked to higher fluoroquinolone resistance in new study from Brazil
Clinicians need to better understand how to reduce the growth of antibiotic-resistant, more virulent bacteria, the authors said